A 4-year-old boy from Delhi presents with a 3-week history of fever, pallor, and petechiae. On examination, he has hepatomegaly (3 cm below costal margin) and splenomegaly (4 cm). CBC shows Hb 7.2 g/dL, WBC 85,000/μL with 70% blasts, and platelets 35,000/μL. Bone marrow aspiration confirms acute lymphoblastic leukemia (ALL). The child is hemodynamically stable with normal renal function and normal uric acid level. What is the most appropriate next step in management?

Explanation

## Management of Newly Diagnosed ALL: Pre-Treatment Stabilization ### Clinical Context This child has newly diagnosed ALL with high WBC count (85,000/μL) and organomegaly — a high-risk presentation for **tumor lysis syndrome (TLS)**. Although he is currently hemodynamically stable with normal renal function and normal uric acid, the disease burden is substantial. ### Why Pre-Treatment Stabilization is Essential **Key Point:** Before initiating cytotoxic chemotherapy in high-burden leukemia, the patient must be stabilized to prevent acute tumor lysis syndrome (TLS), which can cause hyperkalemia, hyperuricemia, hyperphosphatemia, and acute kidney injury. **High-Yield:** The sequence is: **Hydration → Uric acid reduction → Monitor → Then chemotherapy**. This prevents the catastrophic metabolic derangements that occur when leukemic cells lyse rapidly. ### Pre-Treatment Measures | Intervention | Rationale | Timing | |---|---|---| | IV hydration (2–3 L/m²/day) | Maintains urine output >200 mL/m²/hr; dilutes uric acid | Immediately | | Allopurinol (10 mg/kg/day, max 800 mg) | Inhibits xanthine oxidase; prevents uric acid formation | Immediately | | Rasburicase (0.2 mg/kg) | Converts uric acid to allantoin (if available); preferred in high-risk | Consider if high-risk | | Avoid loop diuretics | Increases uric acid precipitation in renal tubules | — | | Monitor K⁺, uric acid, phosphate, creatinine | Detect early TLS | Q6–12 hrs initially | | Alkalinize urine (sodium bicarbonate) | Increases uric acid solubility (if using allopurinol, not rasburicase) | Conditional | **Clinical Pearl:** Lumbar puncture for CNS prophylaxis should be performed *after* the patient is stabilized and chemotherapy is about to start, not before. Performing LP in a patient with high WBC and risk of TLS can precipitate neurological complications. ### Timeline 1. **Hours 0–24:** Aggressive hydration, allopurinol, monitor electrolytes and uric acid 2. **Hours 24–48:** Confirm stabilization; check renal function, electrolytes, uric acid 3. **Day 2–3:** Once stable, initiate induction chemotherapy and CNS prophylaxis (LP) **Warning:** Starting chemotherapy immediately without pre-treatment stabilization risks fatal hyperkalemia, acute kidney injury, and seizures from TLS. ### Why Not the Other Options? - **Option 0 (Immediate chemotherapy):** Risks uncontrolled TLS; violates standard pre-treatment protocol. - **Option 1 (LP after 48 hrs hydration):** LP should be done *with* or *just before* chemotherapy initiation, not as a standalone step; also omits critical pre-treatment stabilization measures. - **Option 3 (Allogeneic transplant):** Transplantation is considered for high-risk ALL (e.g., Philadelphia-positive, poor early response) *after* induction and consolidation, not as first-line management. [cite:Gupta & Sarin Pediatric Hematology-Oncology Ch 5; NCCN ALL Guidelines 2023]